Exact Sciences Corp (EXAS) concluded trading on Thursday at a closing price of $47.16, with 4.94 million shares of worth about $232.89 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.00% during that period and on May 01, 2025 the price saw a gain of about 3.33%. Currently the company’s common shares owned by public are about 185.62M shares, out of which, 182.93M shares are available for trading.
Stock saw a price change of 3.42% in past 5 days and over the past one month there was a price change of 8.54%. Year-to-date (YTD), EXAS shares are showing a performance of -16.07% which decreased to -19.77% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $39.97 but also hit the highest price of $72.83 during that period. The average intraday trading volume for Exact Sciences Corp shares is 2.33 million. The stock is currently trading 6.94% above its 20-day simple moving average (SMA20), while that difference is up 3.78% for SMA50 and it goes to -15.46% lower than SMA200.
Exact Sciences Corp (NASDAQ: EXAS) currently have 185.62M outstanding shares and institutions hold larger chunk of about 99.54% of that.
The stock has a current market capitalization of $8.76B and its 3Y-monthly beta is at 0.92. It has posted earnings per share of -$5.56 in the same period. It has Quick Ratio of 1.92 while making debt-to-equity ratio of 1.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EXAS, volatility over the week remained 3.65% while standing at 6.20% over the month.
Stock’s fiscal year EPS is expected to rise by 93.96% while it is estimated to increase by 275.94% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on April 10, 2025 offering an Outperform rating for the stock and assigned a target price of $60 to it. Coverage by RBC Capital Mkts stated Exact Sciences Corp (EXAS) stock as a Sector perform in their note to investors on March 13, 2025, suggesting a price target of $52 for the stock. On January 23, 2025, Barclays Initiated their recommendations, while on August 28, 2024, Wells Fargo Initiated their ratings for the stock with a price target of $75. Stock get a Sector outperform rating from Scotiabank on June 27, 2024.
